-
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
Wednesday, August 14, 2024 - 2:13pm | 572Kaya Holdings, Inc. (OTCQB:KAYS), a company engaged in the emerging psilocybin treatment sector and medical/recreational cannabis, has voiced strong criticism of the FDA’s decision to reject MDMA therapy as a treatment for post-traumatic stress disorder (PTSD). KAYS, which operates The Sacred...
-
Kaya Holdings Touts International Potential After Buying 50% Stake In Athens-Based Greekkannabis
Thursday, January 14, 2021 - 12:30pm | 286Cannabis company Kaya Holdings Inc. (OTCQB: KAYSD) agreed to buy a 50% interest in Athens, Greece-based Greekkannabis SA. Through its subsidiary, Kaya Brands International Inc., the company initially acquired a 25% interest in Greekkannabis via a share transfer deal with current...